[1] 嵇婷婷, 叶伟, 赵伟. 全身炎性反应综合征在乙型肝炎肝硬化合并腹水患者住院结局中的临床意义[J/CD]. 新发传染病电子杂志, 2020, 5(1): 20-24. [2] 宿慧, 吴静, 刘红, 等. 肝硬化患者血清学和超声心动图检查对肝硬化心肌病的早期诊断价值[J]. 中国临床医生杂志, 2018, 46(8): 921-923. [3] 简佑容, 陈世耀. 肝硬化门脉高压症患者心脏功能影响因素及其状况评价[J]. 实用肝脏病杂志, 2018, 21(3): 336-339. [4] 卢利红, 吴其明, 宋毓青, 等. 病毒性肝炎肝硬化患者的心电图特点分析[J]. 中国医药, 2019, 14(11): 1617-1619. [5] 杜谕君, 陈俊莲, 陈莉, 等. 生长抑素对肝硬化食管胃静脉曲张破裂出血患者心电图QT间期的影响[J]. 肝脏, 2021, 26(7): 724-726. [6] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J].中国医学前沿杂志(电子版), 2019, 11(12):51-77. [7] 黄宛. 临床心电图学[M]. 北京: 人民卫生出版社, 1998: 77-82. [8] CHOUHAN MD, FITZKE HE, BAINBRIDGE A, et al.Cardiac-induced liver deformation as a measure of liver stiffness using dynamic imaging without magnetization tagging-preclinical proof-of-concept, clinical translation, reproducibility and feasibility in patients with cirrhosis[J]. Abdom Radiol (NY), 2021, 46(10): 4660-4670. [9] 谭莉, 方雪琴. 不同程度肝硬化患者内脏血管舒张和门体分流功能差异性分析[J]. 贵州医药, 2021, 45(9): 1460-1462. [10] HIETANEN S, HERAJARVI J, LEHTONEN A, et al.Treatment profile and long-term outcome of intensive care unit-admitted patients with liver cirrhosis or other liver disease in relation to alcohol consumption[J]. Scand J Gastroenterol, 2021, 56(2): 180-187. [11] 胡星, 孟繁坤, 韩晶, 等. 应用超声心动图评估肝硬化患者心脏结构和功能临床价值研究[J]. 实用肝脏病杂志, 2020, 23(2): 252-255. [12] 张晓雪, 金清龙, Giannelli V, 等. 心功能、难治性腹水和β受体阻滞剂对行肝移植的肝硬化患者预后的影响[J]. 临床肝胆病杂志, 2020, 36(3): 630-630. [13] 袁梅, 朱宏英, 李旻昊. 重型肝炎患者体表心电图QTc变化与预后[J]. 肝脏, 2019, 24(11): 1278-1279. [14] 刘晓颖, 王梅, 李真. 酒精性肝硬化并发QT间期延长1例[J]. 大连医科大学学报, 2018, 40(1): 93-94. [15] ZHANG Z, DING R, LU W, et al.Performance evaluation of hbsag by lumipulse hbsag-hq: the agreement with hbsag by architect hbsag-qt and the effectiveness in predicting liver tissue pathological states of chronic hepatitis b patients[J]. Adv Clin Exp Med, 2018, 27(8): 1045-1054. [16] MAZUMDER NR, VANWAGNER LB.QT and outcomes in cirrhosis: a prolonged debate on causality in need of correction[J]. Am J Transplant, 2021, 21(2): 451-452. [17] TAHATA Y, SAKAMORI R, URABE A, et al.Liver fibrosis is associated with corrected qt prolongation during ledipasvir/sofosbuvir treatment for patients with chronic hepatitis c[J]. Hepatol Commun, 2018, 2(8): 884-892. [18] TSIOMPANIDIS E, SIAKAVELLAS SI, TENTOLOURIS A, et al.Liver cirrhosis-effect on qt interval and cardiac autonomic nervous system activity[J]. World J Gastrointest Pathophysiol, 2018, 9(1): 28-36. [19] BISELLI M, GRAMENZI A, LENZI B, et al.Development and validation of a scoring system that includes corrected qt interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding[J]. Clin Gastroenterol Hepatol, 2019, 17(7): 1388-1397. [20] KIM HM, KIM HK, LEE JH, et al.Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study[J]. J Cardiovasc Magn Reson, 2020, 22(1): 25-25. |